NAPRT and neoplasm: To further confirm the observed sensitization effect of our putative inhibitors on the anti-tumor activity of NAMPT inhibitors, we extended our experiments in two additional NAPRT-expressing cancer cell lines (i.e., HCT116 and OVCAR-8).